Acrivon Therapeutics shares owned by Geode Capital Management
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Geode Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $348k | 192k | 1.81 |
| 2025-06-30 | $196k | 164k | 1.19 |
| 2025-03-31 | $622k | 306k | 2.03 |
| 2024-12-31 | $1.8M | 301k | 6.02 |
| 2024-09-30 | $2.1M | 302k | 7.00 |
| 2024-06-30 | $1.8M | 308k | 5.80 |
| 2024-03-31 | $1.7M | 243k | 7.15 |
| 2023-09-30 | $1.8M | 190k | 9.56 |
| 2023-06-30 | $2.3M | 179k | 12.96 |
| 2023-03-31 | $2.2M | 175k | 12.69 |